MedPath

Fasting gastric volume comparison between diabetic and non-diabetic preoperative patients

Not yet recruiting
Conditions
Endocrine, nutritional and metabolic diseases,
Registration Number
CTRI/2024/03/063929
Lead Sponsor
Goa Medical College
Brief Summary

PreoperativeUltrasonographic Comparison of Fasting

GastricVolume In Diabetic &  Non-DiabeticPatients :

ProspectiveAnalytical Observational Study

 Candidate: Dr Eldho Joy

Junior resident

Department of Anaesthesiology

Goa Medical College , Bambolim ,Goa

 Guide: Dr Shirley Ann D’Souza

Professor and HOD

Department of Anaesthesiology

Goa Medical College , Bambolim ,Goa

 Introduction

• Point of care gastric ultrasonography is a simple,

readily available, non invasive & easy to perform

diagnostic tool to examine the volume of gastric

content and determine pulmonary aspiration risk

• Data on fasting gastric content and volume in

preoperative patients with Diabetes Mellitus is

limited and contradictory . Hence the present

study

 Aim & Objectives

ʉۢ Research Question: Whether the gastric volume is

more than the safe limit in diabetic as compared

to non - diabetic patients despite adequate

fasting?

• Primary objective – To determine and compare

the residual gastric volume in preoperative

diabetic and non-diabetic patients.

• Secondary objective –To study the fasting gastric

volume in relation to

1.Control of diabetes in terms of HbA1c &

2. Duration of diabetes.

 Materials and Methods

• Study design – Prospective, Analytical

Observational study

• Study Setting – Preoperative Area Of Operation

Theatre in Goa Medical College

• Study Duration – March 2024 - March 2025

• Sampling Method – Universal Sampling

• Sample Size – Total 80 (40 Diabetic & 40 Non-

Diabetic)

   n = sample size

 All statistical calculation will be done using SPSS

software .

 Inclusion Criteria

ʉۢ Patients scheduled for elective surgery with

preoperative fasting period of 8-10 hours

• Age: 18-65 years

• Sex: Either sex

• ASA physical status: I, II

• Body mass index < 30kg/m 2

 Exclusion Criteria

ʉۢ Pregnant patient

• Gastroesophageal reflux disease

• Recent abdominal trauma/ previous

gastrointestinal surgery

• Patients who are unable to turn & lie in right

lateral position

• Patients with nasogastric tube in situ

• Conditions/ drugs that alter gastric emptying

 Procedure

 Patients will be divided into 2 groups based on

diagnosis of Diabetes Mellitus

Group A (Diabetic)

Group B (Non Diabetic)

• Ultrasonography in preoperative waiting area will

be done with

• A portable ultrasound machine with curved array

low frequency (2-5MHz) probe.

• The epigastrium will be scanned in sagittal plane in

Supine position followed by Right Lateral

Decubitus (RLD) position.

 The gastric antrum is identified just below the leftlobe

of liver and pancreas where the aorta and inferiorvena

cava serve as important vascular landmark.

The sonographic appearance of gastric antrum is

classified as

Grade 1-empty antrum

Grade 2-fluid detected in right lateral position only

Grade 3-antral fluid in both supine and right lateral

position

 Empty Antrum - Bulls-eye’ appearance

Thick muscularis propria layer

Clear fluid - Hypoechoic ,distended antrum

Gastric antrum

(A) containing fluid with some air bubbles

(B) containing fluid with ‘starry night’ appearance

Solids- distended antrum

(C) After recent ingestion of solids, with a ‘frosted

glass’ appearance.

(D) Gastric antrum containing solids, in later stage

shows hyperechoic heterogeneous consistency

representing different consistency of solids consumed

 Quantitative Assessment

ʉۢ Cross-sectional area (CSA) is calculated by using

two perpendicular diameters :

Antero-Posterior(AP) &amp; Cranio-Caudal (CC)&amp;

the formula CSA=( AP x CC x Ï€ ) /4

Perlas formula

Gastric residual volume(ml) =

27.0+ 14.6 x right lateral CSA – 1.28 x age

 PATIENTS INFORMATION SHEET

 Title - Preoperative Ultrasonographic Comparison ofFasting Gastric Volume In Diabetic &amp; Non-

Diabetic Patients.

Introduction – We would like to invite you toparticipate in the research project . Before you

decide you need to understand why the research isbeing done and what will it involve for you.

Please read this information sheet carefully and askquestions about anything you do not

understand .You can also talk to others before youdecide.

Purpose of the study- To determine and compare theresidual gastric volume in preoperative

diabetic and non-diabetic patients.

Whether the gastric volume is more than the safe limitin diabetic as compared to non - diabetic

patients despite adequate fasting.

Risks to you- no risk.

Benefits to you- Based on the results of the study ,we will be able to examine stomach contents

and determine pulmonary aspiration risk by a non invasiveway.

.Participating in the study will not provide you anyfinancial or medical benefit.

Confidentiality-

All data collected will be kept confidential.

Do I have to take part ? - You will be included in thestudy only after voluntary consent.

Your right to withdraw-

Its not compulsory that you have to participate in thestudy .Even after your consent for the study

,you are free to withdraw from it at any given pointof time.

If you have any problems or questions regarding thestudy ,please feel free to contact any of the

investigator whose details are given below .

Problems or Questions -

You will be given a copy of this form .If you have anyproblems or questions regarding the study

,please feel free to contact any of the investigatorwhose details are given below . You will be asked

to provide your contact details so that the studyorganizers can contact you.

Investigators details – Dr Eldho Joy, Junior Resident.

Phone number- 8552837062

Address- GARD Hostel , Goa medical college, Bambolim,Goa .

In case of any ethical issue please contact- MemberSecretary, Institutional Ethical Committee, Goa

Medical College, Goa.

 CONSENT FORM FOR PARTICIPANTS

 I             ,confirm that I have read andunderstood the participants information sheet

for the above study titled as ‘PreoperativeUltrasonographic Comparison of

Fasting Gastric Volume In Diabetic & Non-DiabeticPatients ‘.

I am aware that my participation in this study isvoluntary and I have the right to withdraw

from this study at any point of time without statingmy reasons for it and without my right

being affected.

I understand that all information collected from mewill be kept strictly confidential and no

information will be given to anyone includinginstitutional authorities, apart from the study

investigators.

I understand that this study will involve :

Collection of my personal and clinical details.

Collection of investigational reports.

I understand that the information I provide will beused only to fulfill the above stated

objective and will not be used in any way that isharmful or discriminatory against me.

I agree that the data or the results that arise fromthe study can be used for a scientific

purpose . I understand that there are no monetarybenefits to me from this study.

Signature of the participant / custodian-

Name of the participant / custodian-

Signature of witness –

Signature of the Investigator-

Name and details of investigator –

Contact number of investigator-

Date-

 Time-

 PROFORMA

 Hospital registration number:

Date

 DIABETIC                                   NONDIABETIC

 Age

Sex

ASA –PS

Weight

Height

BMI

Years since

diagnosis of DM

Medication

Insulin

OHA

Insulin & OHA

HbA1c

Creatinine

DM neuropathy

Hours of fasting

solid

Liquid

 USG

Grade 1

Grade 2

Grade 3

 Antero-

Posterior(AP)

Diameter

(Right Lateral)

 Cranio-Caudal (CC)

Diameter

 CSA=

 Gastric residual

volume(ml) =

27.0+ 14.6 x right

lateral CSA – 1.28 x

age

 REFERENCES

 1. CubillosJ, Tse C, Chan VW, PerlasA. Bedsideultrasound

assessment of gastric content:An observational study.

Can JAnaesth 2012;59:416–23.

2. Van de Putte P, Perlas A. Ultrasound assessment of

gastric content and volume. Br J Anaesth

2014;113:1222.

3. Krishnasamy S,Abell TL. Diabetic gastroparesis:

Principles and current trends in management. Diabetes

Ther 2018;9:1–42.

4. Garg H, Podder S, Bala I, GulatiA. Comparison offasting

gastric volume using ultrasound in diabetic and

nondiabetic patientsin elective surgery: An

observational study. Indian J Anaesth 2020;64:3916.

5. Perlas A, Mitsakakis N, Liu L, Cino M, Haldipur N,Davis L,

et al. Validation of a mathematical model forultrasound

assessment of gastric volume by gastroscopic

examination. Anesth Analg 2013;116:35763.

6. Sabry R, Hasanin A, Refaat S, Abdel Raouf S,Abdallah AS,

Helmy N. Evaluation of gastric residual volume infasting

diabetic patients using gastric ultrasound. Acta

Anaesthesiol Scand 2019;63:6159.

7. Bouvet L, Mazoit JX, Chassard D, Allaouchiche B,Boselli

E, Benhamou D. Clinical assessment of the

ultrasonographic measurement of antral area for

estimating preoperative gastric content and volume.

Anesthesiology 2011;114:108692.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Patients scheduled for surgery with preoperative fasting period of 8-10 hours ASA physical status: I, II and III Body mass index <30kg/m2.

Exclusion Criteria

Pregnant patient Gastroesophageal reflux disease Recent abdominal trauma and previous gastrointestinal surgery Patients who are unable to turn & lie in right lateral position Patients with nasogastric tube in situ conditions and drugs that alter gastric emptying.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the residual gastric volume in preoperativepreoperative fasting period of 8-10 hours
To determine and comparepreoperative fasting period of 8-10 hours
diabetic and non-diabetic patientspreoperative fasting period of 8-10 hours
Secondary Outcome Measures
NameTimeMethod
To study the fasting gastricvolume in relation to

Trial Locations

Locations (1)

Goa Medical College

🇮🇳

Goa, GOA, India

Goa Medical College
🇮🇳Goa, GOA, India
Eldho Joy
Principal investigator
8552837062
eldho.manavalan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.